Hearts For Hospice Medicare Approved Location: 4905 South 1500 West, Suite 210, Riverdale, Utah 84405 Phone: (801) 475-6222 |
News Archive
Vexim, the specialist in minimally invasive anatomical restoration of vertebral compression fractures, today announced the CE Marking and the market launch of its 6.5 mm diameter SpineJack implant, which thus guarantees the technology's compliance and safety.
The Interim Haiti Recovery Commission (IHRC), led by Haitian Prime Minister Jean-Max Bellerive and former President Bill Clinton, recently announced more than $1.6 billion in projects to rebuild Haiti, "including a $200 million plan to create 50,000 new jobs in agriculture," Reuters reports.
Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer's disease (AD) in an animal model representative of most AD patients.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 2 days ago